VNExpress-Dec 29

An oral Covid-19 vaccine developed by Israel will be trialed in Vietnam and is expected to be approved for emergency use in 2023. The OraVax vaccine, produced by Oramed Pharmaceuticals, is already undergoing first phase clinical trials in South Africa. Its commercial partner in Southeast Asia, which aims to transfer the vaccine production technology to Vietnam, is Tan Thanh Holdings. Its manufacturer claims OraVax provides protection even against new variants. Duong Thi Bich Diep, chairwoman of the management board of Tan Thanh Holdings, said after the first phase clinical trial in South Africa is completed, Vietnam would become one of the next regions to trial the vaccine. OraVax would be distributed in Southeast Asian countries like Vietnam, Cambodia, Indonesia, Singapore, Thailand and the Philippines once approved, he added. Vietnam has so far either cooperated for clinical trials or obtained vaccine tech transfer on three Covid-19 vaccines: Sputnik V by Russia, ARCT-15 by the U.S. and a vaccine by Japan’s Shionogi. Read more at: https://e.vnexpress.net/news/news/vietnam-to-trial-israeli-oral-covid-vaccine-4410073.html